OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression
Lihua Fu, Dan Zhang, Nuo Yi, et al.
Human Cell (2022) Vol. 35, Iss. 5, pp. 1560-1576
Closed Access | Times Cited: 22

Showing 22 citing articles:

Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance
Milad Ashrafizadeh, Jingyuan Dai, Pedram Torabian, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 56

Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma
Fenglin Dong, Zongzhen Xu, Ying-Qiao Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10

Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
Nan Zhang, Xinjia Wang, Yu Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1

Nanodrugs based on co-delivery strategies to combat cisplatin resistance
Qiubo Wang, Hui Li, Wu Taixia, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 14-42
Closed Access | Times Cited: 7

RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges
Lele Ye, Xuyang Yao, Binbing Xu, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 14, Iss. 5
Closed Access | Times Cited: 15

Multifaceted roles of insulin‑like growth factor 2 mRNA binding protein 2 in human cancer (Review)
Jianan Shen, Youxiang Ding
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access

Recent advances in the role of circRNA in cisplatin resistance in tumors
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access

IGF2BP2: an m6A reader that affects cellular function and disease progression
Siyi Liu, Shan Liao, Junyu He, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access

The mechanism of copper transporters in ovarian cancer cells and the prospect of cuproptosis
Jiahuan Guo, Yue Sun, Guoyan Liu
Journal of Inorganic Biochemistry (2023) Vol. 247, pp. 112324-112324
Closed Access | Times Cited: 11

RNA binding proteins in cancer chemotherapeutic drug resistance
Hemanathan Vembuli, Ravi Gor, Satish Ramalingam, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3

Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8

Circ-AMOTL1 enhances cardiac fibrosis through binding with EIF4A3 and stabilizing MARCKS expression in diabetic cardiomyopathy
Yang Yang, Huan Yang, Chong Yang
Cellular Signalling (2023) Vol. 111, pp. 110853-110853
Closed Access | Times Cited: 8

The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From Molecular mechanism to future potential
Mohaddese Malek Mohammadi, Hamidreza Rismanchi, Shakiba Esmailzadeh, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1280-1291
Open Access | Times Cited: 2

Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
Yumin Qiu, Yan Chen, Oluwatobi Agbede, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5711-5711
Open Access | Times Cited: 9

The Emerging Role of IGF2BP2 in Cancer Therapy Resistance: From Molecular Mechanism to Future Potential
D Li, Shi‐Qi Hu, Jiarong Ye, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12150-12150
Open Access | Times Cited: 1

Molecular mechanisms of cisplatin resistance in ovarian cancer
Chenying Jiang, Chenjun Shen, Maowei Ni, et al.
Genes & Diseases (2023) Vol. 11, Iss. 6, pp. 101063-101063
Open Access | Times Cited: 3

Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer
Jia Yuan, Xin Li, Fanchen Wang, et al.
Experimental Biology and Medicine (2023)
Open Access | Times Cited: 3

The role of circular RNA targeting IGF2BPs in cancer—a potential target for cancer therapy
Xia Luo, Jiaxin Shi, Siyuan Wang, et al.
Journal of Molecular Medicine (2024)
Closed Access

Novel insights into cuproptosis inducers and inhibitors
Ligang Zhang, Ruiting Deng, Lian Liu, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access

The role of circRNAs in regulation of drug resistance in ovarian cancer
Jun Zhan, Zhiyi Li, Changsheng Lin, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1

Page 1

Scroll to top